Brief: Giant Biogene Holding Posts FY Earnings Attributable Of RMB1,002.0 Mln, Up 21.0%
27/03/2023 11:37
March 27 (Reuters) - Giant Biogene Holding Co Ltd
2367.HK :
* FY EARNINGS ATTRIBUTABLE RMB1,002.0 MILLION, UP 21.0%
* FY REVENUE RMB2,364.4 MILLION VERSUS RMB1,552.5 MILLION
Further company coverage: 2367.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan